Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ortoma
Gothenburg, Västra Götaland, Swedenortoma.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Ortoma’s OTS™ platform has CE mark approval in Europe and FDA clearance in the US for its hip replacement module. The company’s AI-driven system enables 3D pre-operative planning, surgical navigation, and post-operative verification to improve precision and outcomes in orthopedic surgeries. Clinical use has been established for the hip module; spine and knee modules are advancing through regulatory processes[1][2].
- Therapeutic areas
- RheumatologyNeurology
- Modalities
- DeviceSoftware
- Industry
- Surgical Medical Devices
02
Partnerships
Zimmer GmbHDepuy International
Beyond the preview
Go deeper on Ortoma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ortoma.